Handelsinvest Investeringsforvaltning’s Kyntra Bio KYNB Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,856	Closed	-$2.64M	–	122
2019 Q3	$2.64M	Hold	2,856	–	–	0.58%	50
2019 Q2	$3.23M	Hold	2,856	–	–	0.68%	50
2019 Q1	$3.88M	Hold	2,856	–	–	0.86%	39
2018 Q4	$3.3M	Hold	2,856	–	–	0.82%	41
2018 Q3	$4.34M	Hold	2,856	–	–	0.89%	38
2018 Q2	$4.47M	Hold	2,856	–	–	0.98%	36
2018 Q1	$3.3M	Hold	2,856	–	–	0.73%	44
2017 Q4	$3.38M	Hold	2,856	–	–	0.75%	41
2017 Q3	$3.84M	Hold	2,856	–	–	0.9%	35
2017 Q2	$2.31M	Buy	2,856 +1,448	+103%	+$1.01M	0.58%	41
2017 Q1	$868K	Hold	1,408	–	–	0.25%	81
2016 Q4	$753K	Hold	1,408	–	–	0.26%	77
2016 Q3	$729K	Hold	1,408	–	–	0.26%	83
2016 Q2	$578K	Hold	1,408	–	–	0.22%	85
2016 Q1	$749K	Buy	+1,408	New	+$702K	0.25%	101

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's KYNB Position: Q4 2019 in Review

Handelsinvest Investeringsforvaltning sold out of Kyntra Bio (KYNB) in Q4 2019, closing a stake of 2,856 shares — an estimated $2.64M sold.

Handelsinvest Investeringsforvaltning first reported a position in KYNB in Q1 2016 and held it in 15 quarters. The position peaked at $4.47M in Q2 2018. 213 funds tracked by Wall St. Rank hold KYNB as of Q4 2019.

Handelsinvest Investeringsforvaltning reported no remaining Kyntra Bio position as of Q4 2019 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 2,856 Kyntra Bio shares in Q4 2019, an estimated $2.64M.
Handelsinvest Investeringsforvaltning first reported a position in Kyntra Bio in Q1 2016 and held it in 15 quarters.
Handelsinvest Investeringsforvaltning's Kyntra Bio position peaked at $4.47M in Q2 2018.
213 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2019, filed 30 Jan 2020.